Trials / Conditions / Central Diabetes Insipidus

Central Diabetes Insipidus

8 registered clinical trials studyying Central Diabetes Insipidus — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healt NCT06808516	University Hospital, Basel, Switzerland	Phase 2
Not Yet Recruiting	Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children NCT06604975	Assistance Publique Hopitaux De Marseille	N/A
Recruiting	Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficie NCT06789705	University Hospital, Basel, Switzerland	N/A
Completed	Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study) NCT05319301	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	N/A
Completed	Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) NCT04897802	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	Phase 4
Completed	Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study) NCT04902235	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	Phase 4
Unknown	Seoul National University Pituitary Disease Cohort Study NCT03474601	Seoul National University Hospital	—
Completed	A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI). NCT01280188	Ferring Pharmaceuticals	Phase 3